Eli Lilly Total Long Term Liabilities 2010-2024 | LLY

Eli Lilly total long term liabilities for the quarter ending December 31, 2024 were $36.067B, a 39.53% increase year-over-year.

  • Eli Lilly total long term liabilities for 2024 were $36.067B, a 39.53% increase from 2023.
  • Eli Lilly total long term liabilities for 2023 were $25.849B, a 19.81% increase from 2022.
  • Eli Lilly total long term liabilities for 2022 were $21.576B, a 12.29% decline from 2021.

Eli Lilly Total Long Term Liabilities 2010-2024 | LLY

  • Eli Lilly total long term liabilities for 2024 were $36.067B, a 39.53% increase from 2023.
  • Eli Lilly total long term liabilities for 2023 were $25.849B, a 19.81% increase from 2022.
  • Eli Lilly total long term liabilities for 2022 were $21.576B, a 12.29% decline from 2021.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B